by Steve Lundeberg, Oregon State University A compound given as a dietary supplement to overweight but otherwise healthy people in a clinical trial caused many of the patients to slim down, research by Oregon State University and Oregon Health & Science University showed. The research, published in the Journal of Nutrition, analyzed the effects of...
Lipoic acid reduced brain shrinkage in patients with secondary progressive MS Compared to a placebo, it improved atrophy by 68% Portland researchers found In comparison, FDA-approved drug ocrelizumab showed reduction of just 18% People with SPMS don’t recover from relapses and see a worsening of disability There’s no known cure for this or any type of...
